Cargando…

Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis

PURPOSE: We estimated the cost-effectiveness of 4 radiotherapy modalities to treat early breast cancer in the UK. In a subgroup of patients eligible for all modalities, we compared whole-breast (WB) and partial breast (PB) radiotherapy delivered in either 15 (WB15F, PB15F) or 5 fractions (WB5F, PB5F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glynn, David, Bliss, Judith, Brunt, Adrian Murray, Coles, Charlotte E., Wheatley, Duncan, Haviland, Joanne S., Kirby, Anna M., Longo, Francesco, Faria, Rita, Yarnold, John R., Griffin, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672618/ https://www.ncbi.nlm.nih.gov/pubmed/36396774 http://dx.doi.org/10.1007/s10549-022-06802-1

Ejemplares similares

Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials
por: Haviland, Joanne S, et al.
Publicado: (2018)

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
por: Coles, Charlotte E, et al.
Publicado: (2017)

Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial
por: Bhattacharya, Indrani S., et al.
Publicado: (2019)

Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial
por: Bhattacharya, Indrani S., et al.
Publicado: (2019)

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer
por: Brunt, Adrian Murray, et al.
Publicado: (2020)

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial
por: Brunt, A. Murray, et al.
Publicado: (2016)

Changes in radiotherapy fractionation—breast cancer
por: Yarnold, John
Publicado: (2019)

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
por: Murray Brunt, Adrian, et al.
Publicado: (2020)

A multicentre study of the evidence for customized margins in photon breast boost radiotherapy
por: Harris, Emma J, et al.
Publicado: (2016)

Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trial
por: Bhattacharya, Indrani S., et al.
Publicado: (2019)

Women's Free-text Comments on their Quality of Life: An Exploratory Analysis from the UK Standardisation of Breast Radiotherapy (START) Trials for Early Breast Cancer
por: Mills, J., et al.
Publicado: (2018)

Hypofractionation: The standard for external beam breast irradiation
por: Brunt, Adrian Murray, et al.
Publicado: (2023)

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
por: Bartlett, Frederick R., et al.
Publicado: (2014)

Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design
por: Bhattacharya, Indrani S., et al.
Publicado: (2021)

Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy
por: Westbury, Charlotte B, et al.
Publicado: (2014)

Breast cancer risk feedback to women in the UK NHS breast screening population
por: Evans, D Gareth R, et al.
Publicado: (2016)

Cancer risk after radiotherapy for breast cancer
por: Levi, F, et al.
Publicado: (2006)

Impact of diabetes on surgery and radiotherapy for breast cancer
por: Lawrenson, Ross, et al.
Publicado: (2023)

Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer?
por: Bhattacharya, I.S., et al.
Publicado: (2018)

Meat consumption and risk of breast cancer in the UK Women's Cohort Study
por: Taylor, E F, et al.
Publicado: (2007)

Dietary acrylamide intake and risk of breast cancer in the UK women's cohort
por: Burley, V J, et al.
Publicado: (2010)

Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer
por: de Boer, Anna Z., et al.
Publicado: (2019)

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries
por: Berrington de Gonzalez, A, et al.
Publicado: (2010)

The fraction of breast cancer attributable to smoking: The Norwegian women and cancer study 1991–2012
por: Gram, Inger T, et al.
Publicado: (2016)

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors
por: Cooke, R, et al.
Publicado: (2013)

Are lower rates of surgery amongst older women with breast cancer in the UK explained by co-morbidity?
por: Lavelle, K, et al.
Publicado: (2012)

The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience
por: Crolley, Valerie E., et al.
Publicado: (2020)

Cancer-specific mortality in breast cancer patients with hypothyroidism: a UK population-based study
por: McVicker, Lauren, et al.
Publicado: (2022)

Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
por: Horwich, A, et al.
Publicado: (2014)

Dietary exposure to polychlorinated biphenyls and risk of breast, endometrial and ovarian cancer in a prospective cohort
por: Donat-Vargas, Carolina, et al.
Publicado: (2016)

Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
por: Frisk, Gabriella, et al.
Publicado: (2017)

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age
por: Drooger, Jan C., et al.
Publicado: (2015)

Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews
por: Hackett, Julia, et al.
Publicado: (2018)

Breast cancer worry in higher-risk women offered preventive therapy: a UK multicentre prospective study
por: Lloyd, Kelly E., et al.
Publicado: (2021)

Rates and predictors of consideration for adjuvant radiotherapy among high-risk breast cancer patients: a cohort study
por: Krotneva, Stanimira, et al.
Publicado: (2013)

Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals
por: van Ravesteyn, N T, et al.
Publicado: (2011)

Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study
por: Johns, Louise E, et al.
Publicado: (2018)

Is the biology of breast cancer changing? A study of hormone receptor status 1984–1986 and 1996–1997
por: Brown, S B F, et al.
Publicado: (2009)

Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study
por: Walters, S, et al.
Publicado: (2013)

Descriptive Epidemiology of Cardiorespiratory Fitness in UK Adults: The Fenland Study
por: GONZALES, TOMAS I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uamfktgbbdc1roje97lg19b0b5